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Treatment of infected tunneled venous access hemodialysis catheters
with guidewire exchange. Cuffed venous access catheters have become
commonplace for hemodialysis access. The major complications of these
catheters are catheter thrombosis, catheter fibrin sheathing and infection.
When catheter associated bacteremia occurs treatment with antimicrobial
therapy alone has been unsuccessful in providing acceptable cure rates.
Failed antimicrobial therapy exposes the patient to the risks of prolonged
bacteremia, while the alternative, catheter replacement at a new site can
lead to central venous stenosis and compromise future long-term upper
extremity access. Catheter guidewire exchange when the tunnel tract is
clinically not infected theoretically allows the preservation of future access
sites and yields a higher treatment success rate while avoiding temporary
non-cuffed access placement. We report a series of 23 cases of hemodi-
alysis patients with tunneled cuffed catheters and bacteremia related to
the catheter who were treated with the exchange of a new catheter over a
guidewire combined with three weeks of systemic antibiotics. Patients
eligible for the study required no evidence of tunnel tract infection and
defervescence within 48 hours of antimicrobial therapy. Technique failure
was defined as repeat infection from any organism within 90 days of
catheter exchange. Four patients (18%) redeveloped bacteremia within 90
days of the exchange. The bacteremias developed at 4, 19, 63 and at 74
days days after the exchange. Guidewire exchange in combination with
intravenous antibiotics in cases of catheter related bacteremia has an
acceptable rate of treatment success and is a viable treatment option in a
carefully selected patient population.
Cuffed tunneled venous access catheters are commonly used for
temporary and permanent access for hemodialysis patients [1–4].
These catheters serve an essential role providing hemodialysis
access to patients awaiting the maturation or placement of
permanent arteriovenous (AV) access and providing permanent
access in patients in whom all other access options have been
exhausted. The predominant complications with the use of these
tunneled catheters are catheter thrombosis, catheter fibrin sheath-
ing and infection [1–6].
Catheter dysfunction caused by thrombosis has been shown to
respond to a series of therapeutic techniques [5, 7], and in our
experience thrombotic episodes, although frequent, are treatable.
Catheter mediated bacteremia and catheter tunnel infection,
however, are currently the primary reasons for catheter access
failure [5, 6]. In a study from our institution, the mean catheter
life in catheters intended for permanent use was 12.7 months with
almost all catheters lost due to infection [5].
In a prospective study by Marr and colleagues at Duke Univer-
sity, we demonstrated an infection rate of 3.9 infections per 1000
catheter days of use [6], which was consistent with the cuffed
hemodialysis catheter infection rates at other centers [8]. Com-
plication from these infections ranged from minimal systemic
signs to endocarditis, septic arthritis, and epidural abscess. In the
study by Marr and colleagues using the same patient base as the
current study, there were no differences in systemic complications
between those patients in whom catheter salvage was attempted
and in those it whom it was not [6]. However, Kovalik and
colleagues noted an increased frequency of epidural abscesses and
bacterial endocarditis when these catheters were used chronically
when compared to AV access [9]. Thus, infectious complications
have emerged as the dominant problem with long-term chronic
cuffed catheter use.
Cuffed catheter related bacteremia has been treated by at-
tempted salvage with intravenous antibiotics or removal of the
catheter. As reported by Marr et al, the successful rate of salvage
with antimicrobial therapy alone was only 32% [6]. The alternate
clinical approach to attempted catheter salvage has been catheter
removal, with use of temporary access for a period of time
followed by catheter replacement at a new site. With repeated
new sites of access there is an increased risk for the development
of central venous stenosis compromising the longevity of upper
extremity AV access.
Several studies have shown that in the intensive care unit (ICU)
setting, guidewire exchange of non-cuffed catheters may be
successfully performed without any increased risk of infection
compared to placement of a new catheter at a new site [12–17].
This approach, however, has not been universally recommended
[15].
Carlisle et al reported a series of patients with hemodialysis
catheter related sepsis who underwent catheter exchange over a
guidewire who had treatment failures only in the presences of
purulence at the exit site [16]. Shaffer reported a series of thirteen
patients with cuffed tunneled catheter related sepsis who were
treated with antimicrobial therapy and guidewire exchange
[17]. We report here a cohort of patients with systemic
infections associated with cuffed tunneled catheters who were
treated with guidewire exchange in addition to intravenous
antibiotic therapy.
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METHODS
Patients seen at Duke University Medical Center (DUMC) with
clinically suspected catheter related sepsis were evaluated for
potential guidewire exchange. These patients were seen over the
period of July 1, 1996 though September 30, 1997. Requirement
for consideration for guidwire exchange were: (1) end-stage renal
disease (ESRD), (2) bacteremia without an identifiable source
except the catheter, (3) defervescence with intravenous antibiotics
within forty-eight hours, and (4) no sign of catheter tunnel tract
infection. Patients with purulence at the exit site were ineligible
for guidewire exchange. Patients who underwent guidewire ex-
change were continued on antibiotic therapy for three to four
weeks at the discretion of the clinician.
Patients who presented with fever and leukocytosis without an
identifiable infection source except the catheter underwent blood
cultures and received an initial empiric antibiotic therapy of
vancomycin and gentamicin. Patients with positive cultures were
then entered into the study. After culture results, antibiotic
therapy was based on susceptibilities. A treatment failure was
considered any bacteremia within 90 days after exchange.
Patients who met eligibility criteria were taken to the interven-
tional radiology suite for the catheter exchange. The catheters
used in this study were of a single type (Perm Cathy; Quinton
Instrument Co., Seattle, WA, USA). The catheter and skin site
were prepped with a betadyne scrub (33) and the betadyne was
allowed to dry and draped in sterile fashion. Fentanyl and Versed
were administered intravenously for conscious sedation; 10 cc was
aspirated from each catheter port and discarded. Each port was
flushed with 10 cc of heparinized saline (1,500 Units of heparin in
500 cc normal saline). Using fluoroscopic guidance, a stiff shaft
hydrophilic guidewire (Glidewire SS, Medi-tech; Boston Scientific
Corporation, Watertown, MA, USA) 0.035 inches in diameter,
150 cm in length, was passed through each of the two catheter
lumens to the level of the right atrium. The Dacron cuff was
bluntly dissected from the subcutaneous tissue via the tunnel.
Catheters were placed in such a manner that the cuff could be
reached with forceps inserted via the tunnel. The catheter was
exchanged for a new catheter over the guidewires into the same
tunnel. The guidewires were removed and 5 cc were aspirated
from each lumen. Five thousand units of heparin were injected
into each lumen and caps placed on the ports; 2-0 silk was used to
anchor the catheter to the skin for 10 days.
RESULTS
During the study 40 catheter-related infection episodes (fever,
chills, leukocytosis without an identifiable infection source except
the catheter) were evaluated for possible guidewire exchange.
Patients not entered into the study had their catheter removed
either because they were judged clinically unstable (hypotension),
had a possible infected catheter tunnel tract, or failed to become
afebrile within 48 hours of initiation of antibiotic therapy (Table
1).
There were 23 catheter exchanges in 21 patients. The patient
population included 10 men and 11 women with a mean age of 59
years. Seventeen of the catheters were right internal jugular
insertion and 6 were left internal jugular. Catheters had been in
place for a range of one month to 1.6 years. Organisms isolated
from blood cultures were staphylococcus aureus (8 cases), entero-
coccus sp. (3 cases), staphylococcus Coagulase negative (3 cases),
and one case each of diptheroids, serratia marcescans, streptococcus
viridans, E. coli, and hemophilus parainfluenzae, respectively. One
patient had a polymicrobial infection with four organisms. Two
patients had positive catheter tip cultures but negative blood
cultures (both staphylococcus Coagulase negative). One patient
who was initially culture negative later redeveloped fever and
grew Xanthomonas maltophia, which resulted in catheter removal
and treatment failure (Table 2).
There were four treatment failures, defined as bacteremia from
any organism within 90 days of catheter exchange. These failures
occurred at 4, 19, 63, and 78 days post-catheter exchange. The
treatment failure at four days was associated with recurrent fever
and staphylococcus aureus bacteremia. The technique failure at 19
days was with xanthomonas maltophilia in a patient who was
initially blood culture negative. The treatment failure at 63 days
occurred in a patient who initially grew enterococcus but devel-
oped staphylococcus aureus bacteremia at 63 days. The treatment
failure at 78 days was a recurrence of Coagulase negative staphy-
lococcus.
In addition, the patient with a polymicrobial infection with E.
coli, streptococcus viridans, staphylococcus coagulase negative, and
enterococcus sp. bacteremia, developed staphylococcus Coagulase
negative bacteremia and L4-L5 discitis 144 days after the catheter
exchange. It is our belief that this infection represents new and not
recurrent infection, as this patient had developed sacral decubiti
prior to the event. There were no discernable correlations be-
tween organism and treatment failure.
DISCUSSION
This prospective observational series supports the finding by
Shaffer that guidewire exchange of cuffed venous hemodialysis
catheters is a reasonable approach to catheter related bacteremia
in the clinical setting of defervescence within 48 hours after the
administration of intravenous antibiotics in the absence of exit site
infection [9]. Data reported by Marr et al from our institution in
Table 1. Catheter infection outcomes
Catheter bacteremia episodes 40 100%
Immediate catheter removal 17/40 42%
Catheter exchanges 23/40 58%
Exchange technique success
(infection free . 90 days)
19/23 83%
Exchange technique failure
[recurrent infection (any organism)
, 90 days]
4/23 17%
Table 2. Causes of bacteremia
Organism Number of cases
Staphylococcus aureus 8
Enterococcus sp. 3
Staphylococcus Coag neg 5a
Diptheroids sp. 1
Serratia marcescans 1
Escherichia coli 1
Hemophilus Parainfluenza 1
Streptococcus viridans 1
Xanthomonas Maltophilia 1
Polymicrobial 1
a 2 cultures, catheter tip only
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the study that preceded our study documented a very low (32%)
rate of successful catheter salvage with intravenous antibiotics
alone [6]. Although patient selection is different in these studies,
(no exclusion of tunnel tract infections in the study by Marr et al),
the results of our study and the study by Shaffer support the
finding that in the correct clinical setting guidewire exchange can
be done safely.
Due to the high incidence of bacteremia associated with cuffed
venous access catheters, it is unreasonable to expect that there will
be no repeat infections at follow-up. The infection rate 90 days
after exchange in this series is comparable to the rate in de novo
catheter use. Only four of the 23 cases (17%) had a repeat
infection 90 days post-exchange. The series of patients reported
by Shaffer had 3 of 13 cases with repeat bacteremia ranging from
2.5 months to 13 months, with two of three recurrences being with
the originally cultured organism. In our study only one of the four
bacteremias was with the original cultured organism, while one
original culture failed to grow an organism. It is possible that our
treatment failures may represent either a new infection or an
infection introduced at the time of catheter exchange rather than
failure to eradicate the original infection. Regardless of the cause,
all represent a catheter exchange technique failure and are
reported in this manner. This study is also in agreement with the
observations of Beathard (personal communication) that in the
correct setting that catheters can be successfully salvaged by the
use of guidewire exchange.
In conclusion, preservation of access sites is in the best long-
term interest of the dialysis patient. When used in the proper
clinical situation, guidewire catheter exchange can be performed
with a low likelihood of treatment failure. Successful guidewire
exchange can preserve sites of access while allowing the patient to
avoid temporary non-cuffed hemodialysis access placement. We
believe when the conditions of clinical improvement after 48
hours of intravenous antibiotics and absence of tunnel tract
infection are met, then guidewire exchange is a viable treatment
option.
Reprint requests to Steve J. Schwab, M.D. Box 3014, Duke University
Medical Center, Durham, North Carolina 27710, USA.
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